PCM
ARAV

Prelude Capital Management’s Aravive, Inc. Common Stock ARAV Stock Holding History

Prelude Capital Management’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-167
Closed -$21K – 1922
2017
Q1 		$21K Buy
+167
New +$17.6K ﹤0.01% 1276

Other funds holding ARAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Prelude Capital Management's ARAV Position: Q3 2017 in Review

Prelude Capital Management sold out of Aravive, Inc. Common Stock (ARAV) in Q3 2017, closing a stake of 700 shares — an estimated $73K sold.

Prelude Capital Management first reported a position in ARAV in Q1 2015 and held it in 6 quarters. The position peaked at $178K in Q1 2017. 105 funds tracked by Wall St. Rank hold ARAV as of Q3 2017.

  • Prelude Capital Management reported no remaining Aravive, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Prelude Capital Management sold 700 Aravive, Inc. Common Stock shares in Q3 2017, an estimated $73K.
  • Prelude Capital Management first reported a position in Aravive, Inc. Common Stock in Q1 2015 and held it in 6 quarters.
  • Prelude Capital Management's Aravive, Inc. Common Stock position peaked at $178K in Q1 2017.
  • 105 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q3 2017.

Based on Prelude Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.